NSE filing, NSE: EQUITASBNK. Summary written from the filing by ALFA Finder's alert engine.
Equitas Small Finance Bank Ltd: key numbers
- Share price
- ₹65.33
- Market cap
- ₹7,475 Cr
- Revenue (annual)
- ₹6,794 Cr
- Net profit (annual)
- ₹116.0 Cr
- P/E (TTM)
- 14.6×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 15.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Equitas Small Finance Bank Ltd
All →Equitas Small Finance Bank Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026. This is a periodic regulatory compliance filing required under SEBI listing regulations.
Equitas Small Finance Bank Board Meeting Date
Equitas Small Finance Bank will hold a board meeting on 29 Oct 2026 to consider unaudited H1 FY27 standalone results. No financial figures are disclosed.
Equitas Small Finance Bank Credit Rating
Equitas Small Finance Bank announced that CARE Ratings reaffirmed the "CARE AA-; Stable" rating for its issuer, Lower Tier II, and Tier II bond issues.
Equitas Small Finance Bank Employee Stock Options
Equitas Small Finance Bank allotted 4,574 equity shares to employees upon the exercise of stock options under its 2019 ESOP scheme.
Equitas Small Finance Bank Business Update
Equitas Small Finance Bank reported provisional business updates for Q2 FY27, with gross advances reaching ₹50,694 Crore. Total deposits grew to ₹52,483 Crore for the period.
Equitas Small Finance Bank Capacity Expansion
Equitas Small Finance Bank has commenced operations at its new corporate office in Chennai. The relocation of departments is being conducted in a phased manner.
- corporate office
- 1.0 office
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.